JP2016508219A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016508219A5 JP2016508219A5 JP2015548368A JP2015548368A JP2016508219A5 JP 2016508219 A5 JP2016508219 A5 JP 2016508219A5 JP 2015548368 A JP2015548368 A JP 2015548368A JP 2015548368 A JP2015548368 A JP 2015548368A JP 2016508219 A5 JP2016508219 A5 JP 2016508219A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- sample
- bladder cancer
- reference value
- sample value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261739812P | 2012-12-20 | 2012-12-20 | |
| EP12198437.1 | 2012-12-20 | ||
| US61/739,812 | 2012-12-20 | ||
| EP12198437.1A EP2746768A1 (en) | 2012-12-20 | 2012-12-20 | Podxl in bladder cancer |
| PCT/EP2013/076179 WO2014095508A1 (en) | 2012-12-20 | 2013-12-11 | Podxl in bladder cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016508219A JP2016508219A (ja) | 2016-03-17 |
| JP2016508219A5 true JP2016508219A5 (enExample) | 2017-01-26 |
| JP6312700B2 JP6312700B2 (ja) | 2018-04-18 |
Family
ID=47458728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015548368A Active JP6312700B2 (ja) | 2012-12-20 | 2013-12-11 | 膀胱癌中のｐｏｄｘｌ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9354232B2 (enExample) |
| EP (2) | EP2746768A1 (enExample) |
| JP (1) | JP6312700B2 (enExample) |
| AU (1) | AU2013360993A1 (enExample) |
| CA (1) | CA2890762A1 (enExample) |
| WO (1) | WO2014095508A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3282014B1 (en) * | 2015-02-12 | 2023-09-06 | Tohoku University | Cancer cell-specific anti-podocalyxin antibody and method for producing same |
| US11046778B2 (en) | 2016-03-31 | 2021-06-29 | Tohoku University | Anti-podocalyxin antibody that targets tumor microenvironment |
| US12031988B2 (en) * | 2018-10-23 | 2024-07-09 | Hoffmann-La Roche, Inc. | Distance-based tissue state determination |
| KR102909979B1 (ko) | 2023-08-02 | 2026-01-12 | 세종대학교산학협력단 | 항 podxl 단일클론항체 및 이의 용도 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998012564A1 (en) * | 1996-09-19 | 1998-03-26 | Diagnocure Inc. | Immunological composition for detection of bladder cancer and method of using same |
| DE19932688B4 (de) | 1999-07-13 | 2009-10-08 | Scil Proteins Gmbh | Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen |
| GB9917027D0 (en) | 1999-07-20 | 1999-09-22 | Affibody Technology Sweeden Ab | In vitro selection and optional identification of polypeptides using solid support carriers |
| JP5507086B2 (ja) * | 2006-03-06 | 2014-05-28 | エージェンシー フォー サイエンス，テクノロジー アンド リサーチ | ヒト胚性幹細胞の方法及びｐｏｄｘｌの発現 |
| US20060294607A1 (en) * | 2006-03-29 | 2006-12-28 | Applera Corporation | Human podocalyxin alternative-spliced forms and uses thereof |
| EP2524928A1 (en) * | 2011-05-18 | 2012-11-21 | Atlas Antibodies AB | RBM3 in bladder cancer |
| CA2767442A1 (en) * | 2009-07-08 | 2011-01-13 | Actgen Inc. | Antibody having anti-cancer activity |
| EP2315028A1 (en) | 2009-10-26 | 2011-04-27 | Atlas Antibodies AB | PODXL protein in colorectal cancer |
-
2012
- 2012-12-20 EP EP12198437.1A patent/EP2746768A1/en not_active Withdrawn
-
2013
- 2013-12-11 AU AU2013360993A patent/AU2013360993A1/en not_active Abandoned
- 2013-12-11 WO PCT/EP2013/076179 patent/WO2014095508A1/en not_active Ceased
- 2013-12-11 US US14/646,918 patent/US9354232B2/en not_active Expired - Fee Related
- 2013-12-11 JP JP2015548368A patent/JP6312700B2/ja active Active
- 2013-12-11 EP EP13802399.9A patent/EP2936150B1/en not_active Not-in-force
- 2013-12-11 CA CA2890762A patent/CA2890762A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Han et al. | Evaluation of fibroblast growth factor receptor 2 expression, heterogeneity and clinical significance in gastric cancer | |
| Krantz et al. | Biomarker-based therapy in pancreatic ductal adenocarcinoma: an emerging reality? | |
| WO2015172960A1 (en) | Methods and kits for the diagnosis of cancer | |
| MX2009013824A (es) | Proteinas de enlace de antigeno que enlazan par-2. | |
| JP2014144959A5 (enExample) | ||
| JP2012518164A5 (enExample) | ||
| CA2749846A1 (en) | Methods of determining patient response by measurement of her-3 | |
| JP2015533788A5 (enExample) | ||
| NZ609824A (en) | Immunochromatography devices, methods and kits | |
| Kikuta et al. | Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor | |
| JP2009537798A5 (enExample) | ||
| JP2016536568A5 (enExample) | ||
| Dvořáková et al. | Transgelin is upregulated in stromal cells of lymph node positive breast cancer | |
| JP2012518163A5 (enExample) | ||
| Park et al. | Clinicopathological features and prognostic significance of HER2 expression in gastric cancer | |
| WO2015006657A8 (en) | Method for the diagnosis and prognosis of cancer | |
| WO2019089858A3 (en) | Methods of assessing or monitoring a response to a cell therapy | |
| WO2008116178A8 (en) | Systems and methods for diagnosis and prognosis of colorectal cancer | |
| JP2019516104A5 (enExample) | ||
| WO2016161153A3 (en) | Prognostic and diagnostic methods for colorectal cancer | |
| WO2019066617A3 (ko) | 항 c-met 항체 및 이의 용도 | |
| WO2019066620A3 (ko) | 항 c-met 항체 및 이의 용도 | |
| JP2018520366A5 (enExample) | ||
| JP2012515893A5 (enExample) | ||
| WO2016143805A1 (ja) | 膀胱がんの検出方法 |